GL1X · GenesisL1 explorer

MolNFT v1 · #164525 · protein

Crystal structure of CYP124 in complex with inhibitor compound 5'

6T0L: “Crystal structure of CYP124 in complex with inhibitor compound 5'”. X-ray diffraction, 3 ligands (HEM, M8N, CL), 4 pockets (best druggability 0.88). MolNFT v1 #164525 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6T0L
Type
protein
Length
422 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
CYP124 in complex with inhibitor compound 5'
UniProt
P9WPP3
Ligands
HEM, M8N, CL
Pockets
4 · best druggability 0.88

Structure

x-ray diffraction · 1 distinct chain · 51% helix, 12% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACYP124 in complex with inhibitor compound 5'protein42251% helix, 12% strandP9WPP3

Ligands and binding sites

  • HEM · Protoporphyrin IX containing Fe · ligand · chains A
  • M8N · ~{N}-[[[2-methyl-4-(3-methylbutyl) phenyl]amino]methyl]hydroxylamine · ligand · chains A
  • CL · Chloride ion · ion · chains A
  • PG4 · Tetraethylene glycol · additive · 2 copies · chains A
  • PEG · Di(hydroxyethyl)ether · additive · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16580.880.9271HEM, M8N
21680.720.9035empty
3600.420.8217empty
4660.290.7316empty

Compared structures

  • 6T0L · Crystal structure of CYP124 in complex with inhibitor compound 5' · the same entry in another collection · chain A against A, TM-score 1.00
  • P9WPP3 · AlphaFold monomer V2.0 prediction for methyl-branched lipid omega- hydroxylase (P9WPP3) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.